|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
This Schedule contains summary financial information extracted from the
condensed financial statements of Cytomedix, Inc. for the three months ended
June 30, 2000 (unaudited) and is qualified in its entirety by reference to such
financial statements.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> APR-1-2000
<PERIOD-END> JUN-30-2000
<CASH> 5,860,738
<SECURITIES> 0
<RECEIVABLES> 65,124
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 378,581
<PP&E> 299,875
<DEPRECIATION> 23,685
<TOTAL-ASSETS> 6,592,967
<CURRENT-LIABILITIES> 409,548
<BONDS> 14,539
1,625,000
571
<COMMON> 1,054
<OTHER-SE> 4,451,048
<TOTAL-LIABILITY-AND-EQUITY> 6,592,967
<SALES> 129,833
<TOTAL-REVENUES> 129,833
<CGS> 31,091
<TOTAL-COSTS> 31,091
<OTHER-EXPENSES> 3,451,013
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 3,343
<INCOME-PRETAX> (3,283,928)
<INCOME-TAX> 0
<INCOME-CONTINUING> (3,304,240)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,304,240)
<EPS-BASIC> (0.31)
<EPS-DILUTED> (0.31)
</TABLE>
|
|